Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Fair enough CM22, but...
The original poster asked about the disconnect between the SALT and TEK MCAP's.
Lolly has suggested it's the lack of an exit strategy. I believe it's more to do with TEK's poor track record with floats and investor concern that Microsalt may follow the same path, in due course.
What's your rationale as to why investors aren't queuing up to buy TEK, given such a big discount to NAV?
Http://tinyurl.com/52k9khrs
Yeah, I know.....tumbleweed....etc.....🤣
The two previous floats (BELL and LUCY) have suffered dramatic slumps in their respective SP's as their reportable numbers have been poor.
If Microsalt follows this pattern then you could argue that TEK looks overvalued, (Guidents/Shocks valutions are just guesswork). Also, TEK's 77% holding in SALT is locked in for 12 months.
Personally, I think Microsalt will announce a big B2B deal and avoid a meltdown of their SP.
Given the track record I completely understand the reluctance of new investors, hence the NAV/SP disconnect.
I'm holding as I believe at least one of these business (maybe two), will deliver a TEK multibag.
Please DYOR 👍
TEK exercising their warrants in SALT, maybe?
Cliff needs £660,000 to repay Lucy, within 90 days (as of 12th January).
Articles in Laboratory News and LinkedIn;
https://cloud.3dissue.com/2153/2844/6246/laboratorynewsissue12024/index.html?r=59
(Pages 19,20 & 21)
https://www.linkedin.com/posts/valirx-plc_tcro-pdcs-laboratory-activity-7165683569904828416-PEJg?utm_source=share&utm_medium=member_android
Morning Tekkies!,
I did read somewhere that the LUCY numbers are being filed today.
🤞
It's a fairly binary choice Shareworm,
By the end of 2024 we could have a CHK1 Inhibitor and two broad spectrum, worldwide patented molecules - all in the clinic - for just £23 million!!
Or we could be bust, having failed the trial.
So; shape up, or ship out.....other idioms are available...😉
At least the Titanic had lifeboats.
This share feels like the Marie Celeste.
Dr Coxswain has steered us onto the rocks.
Aaarggghhh me hearties.🤪
Lolly,
I agree the lack of an exit strategy could be a small factor.
However, I think you need to accept these are fledgling businesses. Amazon, for example, took nine years to turn a profit.
I don't think Cliff has any idea of when, how, or even if he will exit.
There are so many factors to consider it's not feasible to make such a commitment to investors.
We'll just have to agree to disagree.
That's an excellent profit Sea,
Cliff certainly got the SALT IPO right, in tough market conditions.
I think we've reached a turning point as all four portfolio companies have contracts/deals and income.
Building the businesses is now down to the individual CEO's, Cliff has done his bit.
I expect him to take a back seat and concentrate on new opportunities coming out of Universities.
Let him retire gracefully!! 🤣
Morning Sea,
Has Cliff gone up in your estimation yet? 😜
Lucy results are due on the 20th Feb, I'm hoping for signs of life.
An uptick in sales, reduction in costs and increased margins would be a good start!!
They've still got Reebok to launch, don't give up on Lucy!! 🤣
Welcome back Ratboy!!
Both the LUCY and BELL floats have stumbled and I think there is a fear that SALT could follow the same path, hence the disconnect between NAV and MCAP.
However, there is plenty of commercial traction;
LUCY - Reebok deal
BELL - Innomax deal
SALT - 60,000lb order
GUIDENT - AuveTech orders.
The reseached amongst us are also aware of multiple smaller deals/partnerships in each of the portfolio businesses.
BELL and LUCY are due to report shortly, which may hold the SP down.
I'm following the money (Kight and Dangoor), steady as she goes and hopefully a solid 20p base by the end of Q1.
(I haven't mentioned AI, shocks or the invention evaluation services!!).
The Oakbloke blog is worth a read, if you want a detailed "state of play" review.
The BOD are battening down the hatches.
They'll get 5 million votes from Sanderson, possibly in lieu of some future CLN.
They've cash in the bank and have booted out the resolution.
Got rid of Stella and sidelined Professor Hargreaves.
Change ain't happening.
Lolly, have a listen to Judith Batchelar;
https://ukinvestormagazine.co.uk/reducing-sodium-consumption-and-cardiovascular-disease-with-microsalts-judith-batchelar-obe/
"Improves the "proving" time of bread due to better distribution of the particles."
"Adheres to snacks better than larger particles of salt, less waste in manufacturing".
"Microsalt in prepared products stays salty over the life of the product".
"Better marketing opportunity for products that meet lower salt targets e.g. end of aisle offers".
"Worldwide legislation will force change as per the sugar tax, e.g. reformulation work".
"Historically potassium chloride alternatives had a different flavour and behaved differently, "it just didn't work", "customers rejected products".
Perhaps you like to compare your point of view with that of Judith Batchelar MBE and Microsalt NED?
Here ya go fella;
"Shelf registration, shelf offering, or shelf prospectus is a type of public offering where certain issuers are allowed to offer and sell securities to the public without a separate prospectus for each act of offering and without the issue of further prospectus."
The patent has also been granted, I suspect LUCY will have to attend a delisting hearing and are preparing the groundwork.
That's a wild guess on my part!!
Well OB,
Redx Pharma sold their pre-clinical KRAS Inhibitor programme for $10 million upfront, plus milestone payments, to Jazz Pharma.
If the Barcelona project comes up with right molecules perhaps the Greek dream would be realised!! 👍
LUCY patent granted for Smart Glasses
https://ppubs.uspto.gov/pubwebapp/static/pages/ppubsbasic.html
Run a search for - D1013765